Prostate-specific antigen (PSA) screening for prostate cancer remains controversial due to lack of consistent survival benefits reported from clinical trials, and concerns about harms associated with overtreatment. However, it is … Read More
We are excited to announce an opening for a program manager/research associate to support ongoing research on environmental exposures and access barriers that contribute to prostate cancer disparities. We are … Read More
The Pre2 CAP laboratory’s work was featured in a recent story in Stat News describing growing interest in understanding mechanisms linking neighborhood environments and social stressors to health. Our lab … Read More
Our team recently published an article using registry cohort to examine whether county-level prevalence of prostate-specific antigen (PSA) screening was associated with lower odds of advanced stage prostate cancer, and … Read More
In June 2024, the Harvard Zhu Family Center for Global Cancer Prevention will be launching the third iteration of an online course titled “Geospatial Data Science for Cancer Control and … Read More
The Pre2 CAP laboratory recently coauthored a study published in JAMA Network Open in partnership with the US Veterans Health Administration comparing the magnitude of racial and socioeconomic disparities among … Read More
The Precision Prevention of Prostate Cancer (Pre2 CAP) laboratory received an award from the National Institutes of Health to conduct research on exposure to per- and polyfluroalkyl substances (PFAS) and … Read More